News
SNZZF
0.700
NaN%
--
Senzime AB (publ) reports Q2 results
Seeking Alpha · 07/16 11:11
Senzime Boosts Sensor Sales and Margins Despite U.S. Market Headwinds
TipRanks · 07/16 06:35
Senzime Q2 FY26 operating loss narrows 20% to SEK 23.33 million; net sales fall 4% to SEK 24.67 million
PUBT · 07/16 06:03
BRIEF-Senzime Q2 Adjusted Gross Margin 65.7%
Reuters · 07/16 06:01
Senzime Strikes Landmark Global Patient Monitoring Partnership with Philips
TipRanks · 07/15 19:32
Senzime partners with Philips on development, commercialization of patient monitoring solutions
PUBT · 07/15 19:02
Senzime Sets Webcast and Q&A for Q2 2026 Report
TipRanks · 07/13 10:33
Senzime updates on upcoming Q2 2026 results webcast and live Q&A
PUBT · 07/13 10:07
Senzime wins Brazil approval for TetraGraph neuromuscular monitor
TipRanks · 06/29 07:33
Senzime wins ANVISA approval for TetraGraph system in Brazil
PUBT · 06/29 07:15
Senzime Launches TetraAnalytics to Expand TetraGraph Neuromuscular Monitoring Ecosystem
TipRanks · 06/05 08:33
Senzime Wins Major U.S. Pediatric Contract as New Data Backs Cost-Saving Anesthesia Monitoring
TipRanks · 06/03 10:03
BRIEF-Senzime Secures Contract With U.S. Hospital
Reuters · 06/03 09:52
Senzime launches more sustainable EMG sensor for TetraGraph anesthesia monitoring
TipRanks · 06/01 09:36
Senzime Wins Expanded FDA Clearance for Enhanced TetraGraph Monitoring System
TipRanks · 05/27 09:33
Senzime AB Sees Q1 Dip but Growth Intact
TipRanks · 05/20 07:46
Senzime AGM Approves New Share Classes, Incentive Schemes and Capital Mandate
TipRanks · 05/19 16:08
Senzime bolsters U.S. leadership to drive anesthesia-monitoring growth
TipRanks · 04/29 12:32
Senzime Wins US GPO Deals to Accelerate TetraGraph Hospital Adoption
TipRanks · 04/24 12:03
More
Webull provides a variety of real-time SNZZF stock news. You can receive the latest news about Senzime Ab through multiple platforms. This information may help you make smarter investment decisions.
About SNZZF
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.